Danaher (DHR) Stock Forecast for 2024–2028. Sell or Buy Prediction







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Danaher (DHR) Stock Forecast for 2024–2028. Sell or Buy?

Updated: July 20, 2024 (06:58)

Sector: Healthcare

The share price of Danaher Corp. (DHR) now

Latest session on the 19th of July for
Danaher Corp. is negative
Trading Volume: 2982627
Open: 244.99 /  High: 245.25 /  Low: 241
What analysts predict: $248.66
52-week High/Low: $268.82 / $181.51

50/200 Day Moving Average: $254.95 / $238.05

This figure corresponds to the Average Price over the previous 50/200 days. For Danaher stocks, the 50-day moving average is the resistance level today.

For Danaher stocks, the 200-day moving average is the support level today.

Are you interested in Danaher Corp. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Danaher stock price in 2024, 2025, 2026, 2027, 2028. How much will one Danaher share be worth in 2024 - 2028?

When should I take profit in Danaher stock? When should I record a loss on Danaher stock? What are analysts' forecasts for Danaher stock? What is the future of Danaher stock? We forecast Danaher stock performance using neural networks based on historical data on Danaher stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Danaher stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Danaher shares. This happens once a day.


Historical and forecast chart of Danaher stock

The chart below shows the historical price of Danaher stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Danaher stock price can be found in the table below.

Long-term forecasts by years.

Danaher Stock Prediction: Inventory Destocking and Market Recovery to Shape DHR Forecast

Trend: Bullish
Jul 19, 2024

The trajectory of DHR stocks hinges on several key factors that investors need to watch closely. One of the most significant influencers in the short term is the ongoing inventory destocking in the bioprocessing market. Companies that overstocked due to COVID-19-related supply chain issues are now reducing their inventory levels, which is currently dampening demand for Danaher's bioprocessing products. However, this is a temporary phase, expected to subside and potentially lead to a demand recovery by FY25, boosting Danaher’s stock price in the medium term.

Key Factors Influencing DHR Stock Prices

In addition to inventory adjustments, several other factors are crucial for an accurate DHR stock forecast:

  • Chinese Market Recovery: The Chinese government’s plan to fund equipment upgrades, particularly in healthcare, is expected to bolster Danaher’s sales starting in the second half of 2024 and extending into 2025. This could significantly enhance Danaher stock price predictions by driving growth.
  • Interest Rate Cycle Reversal: Lower-than-expected inflation has fueled speculation about potential interest rate cuts. Reduced borrowing costs could encourage higher capital expenditures among Danaher's customers, increasing demand for its products and positively impacting DHR stock values.
  • Legislative Developments: The delay in the passing of the BioSecure Act is a short-term setback. However, its eventual passage could provide a significant competitive edge to U.S. medtech companies, including Danaher, reinforcing long-term stock prospects.

Analysts can leverage these insights to make more accurate stock price predictions for Danaher. By closely monitoring inventory trends, government funding initiatives in key markets like China, changes in interest rates, and legislative updates, analysts can refine their DHR stock price target predictions. Despite current short-term challenges, the medium to long-term outlook for Danaher appears robust, making DHR a potentially strong buy or hold for patient investors.

Review the original Analysis
About author

High Valuation and Falling Sales: Key Challenges Ahead for DHR Stock Forecast

Trend: Neutral
Jul 16, 2024

Historical Valuation and Forecast Discrepancies

Danaher Corporation (DHR) stock has been a topic of much debate among investors, as its historically high valuation poses significant risks. The current P/E ratio of DHR reflects one of its highest points over the past decade, raising concerns about its sustainability. Analysts warn that a return to pre-pandemic P/E levels could trigger a significant downside of 20% to 30% in DHR stock price. This high valuation creates vulnerability to negative developments and external economic pressures, and analysts should watch for any market sentiment shifts.

Falling sales year-on-year is another critical issue for the company. Despite its robust historical performance, declining sales hint at potential market or operational inefficiencies. For highly valued stocks like DHR, continuous sales decline could lead to significant price corrections as the market recalibrates its expectations.

  • High Valuation and Historical P/E Ratio
  • Falling Sales Year-on-Year
  • Negative Revenue Forecasts
  • Analyst and Management Expectations Mismatch
  • Pandemic Effects on Sales and Margins
  • Complex Business Operations

Another consideration is Danaher’s negative revenue forecasts for 2024, anticipating low single-digit declines, worse than analysts predict. This discrepancy heightens the risk of negative surprises in earnings, leading to market volatility. Analysts must pay attention to the gap between market and management expectations to anticipate potential stock price corrections effectively.

The pandemic's effects on sales and margins, especially in the Biotech segment, have also created challenges. Normalizing post-pandemic demand and margins may prompt investors to revise their growth expectations downward. Consequently, analysts should factor in these post-pandemic adjustments when forecasting DHR stock price.

Finally, the complex nature of Danaher’s operations in biotechnology, diagnostics, and life sciences can complicate assessments for average investors. This complexity can result in fragile investor sentiment, making the stock more susceptible to sharp declines on negative news. Analysts must thoroughly understand these specialized fields to make the most accurate predictions for DHR stock price changes.

In conclusion, the intersection of high valuation, declining sales, revenue forecast discrepancies, post-pandemic adjustments, and complex operations presents a challenging landscape for forecasting DHR stock rates. Analysts must consider these factors comprehensively to create accurate predictions and make informed investment decisions.

Is DHR a good stock to buy? For now, the market signals caution.

Review the original Analysis
About author

Navigating DHR Stock Forecast: Capitalizing on Biotech Boom and Strategic Acquisitions

Trend:
Jun 20, 2024

For investors and analysts closely watching the Danaher Corporation (DHR), the near future presents a landscape rich with transformative changes poised to influence the DHR stock rates significantly. At the crux of these subtle yet impactful shifts are several pivotal factors, paramount among which are the burgeoning secular growth trends in biologics and genomics alongside a meticulously orchestrated capital allocation strategy. These elements together not only promise to reshape the trajectory of DHR stock but also provide an invaluable lens for making nuanced and accurate financial predictions.

Deciphering the Future of DHR Stocks: A Strategic Analysis

Analysts foresee a burgeoning shift towards biologics and genomics, amplifying Danaher's market opportunities exponentially. This anticipation rests on the belief that as medicine gravitates more towards personalized care, the demand for Danaher's diagnostic products, central to these emerging fields, will witness an uptick, reinforcing reasons why DHR stock forecast looks promising and why DHR could be a good stock to buy. Furthermore, Danaher's capital allocation strategy, which harmoniously blends asset acquisition and optimization, is a significant catalyst anticipated to fuel intrinsic value growth, making DHR stock price prediction even more bullish.

However, it's imperative to acknowledge the cyclical headwinds—ranging from excess inventory issues attributed to the COVID-era boom to softer demand signals from China—that currently cloud Danaher's horizon. Analysts and investors would do well to view these challenges as temporary, allowing for a strategic positioning that leverages the anticipated rebound, a crucial insight for anyone contemplating whether to buy or sell Danaher stock.

In summary, mapping out the future rates of DHR stocks hinges on a balanced understanding of these dynamic factors. For those pondering over DHR stock buy or sell decisions, closely monitoring these indicators might just be the key to unlocking potential gains. With strategic analysis and a keen eye on Danaher's navigational prowess through its cyclical challenges, DHR stock price target could well outperform market expectations, making it an enticing proposition for the savvy investor.

Review the original Analysis
About author

Danaher Corporation develops, manufactures and markets professional, medical, industrial and commercial products and services. The company operates in three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of the body, including genes, proteins, metabolites and cells, in order to understand the causes of diseases, identify new therapies and test new drugs remedies and vaccines; Diagnostic business, which offers analytical instruments, reagents, consumables, software and services; and Environmental and Application Solutions, which include a variety of activities, including water quality assessment and product identification. Danaher has facilities for research and development, manufacturing, sales, distribution, service and administrative centers in more than 60 countries.

Danaher daily forecast for a month

Date Target Pes. Opt. Vol., %
Jul 22 245.61 244.34 247.21 1.18
Jul 23 245.47 244.76 246.92 0.88
Jul 24 245.74 245.02 246.77 0.71
Jul 25 243.97 242.97 245.41 1.00
Jul 26 243.14 241.53 243.89 0.98
Jul 27 243.75 242.99 245.31 0.95
Jul 28 244.23 242.65 245.43 1.15
Jul 29 244.89 243.37 246.29 1.20
Jul 30 244.53 243.23 246.38 1.30
Jul 31 242.42 241.11 243.49 0.99
Aug 01 240.39 238.51 241.64 1.31
Aug 02 241.59 240.14 243.30 1.32
Aug 03 243.16 242.14 244.08 0.80
Aug 04 242.99 242.16 243.64 0.61
Aug 05 242.77 240.95 244.35 1.41
Aug 06 243.72 241.82 244.55 1.13
Aug 07 245.11 243.15 246.31 1.30
Aug 08 246.92 245.71 248.70 1.22
Aug 09 247.12 245.46 247.61 0.88
Aug 10 244.94 243.47 246.34 1.18
Aug 11 245.63 243.98 246.37 0.98
Aug 12 244.20 243.23 244.77 0.63
Aug 13 243.10 241.69 244.49 1.16
Aug 14 243.88 242.86 245.18 0.95
Aug 15 242.76 241.18 244.65 1.44
Aug 16 241.81 241.11 242.64 0.63
Aug 17 240.77 239.28 241.33 0.86
Aug 18 239.38 238.20 241.15 1.24
Aug 19 239.52 238.56 240.36 0.75
Aug 20 240.22 238.77 240.70 0.80

Danaher Daily Price Targets


Danaher Stock Forecast 07-22-2024.

Forecast target price for 07-22-2024: $245.61.
Positive dynamics for Danaher shares will prevail with possible volatility of 1.163%.
Pessimistic target level: 244.34
Optimistic target level: 247.21

Danaher Stock Forecast 07-23-2024.

Forecast target price for 07-23-2024: $245.47.
Negative dynamics for Danaher shares will prevail with possible volatility of 0.875%.
Pessimistic target level: 244.76
Optimistic target level: 246.92

Danaher Stock Forecast 07-24-2024.

Forecast target price for 07-24-2024: $245.74.
Positive dynamics for Danaher shares will prevail with possible volatility of 0.707%.
Pessimistic target level: 245.02
Optimistic target level: 246.77

Danaher Stock Forecast 07-25-2024.

Forecast target price for 07-25-2024: $243.97.
Negative dynamics for Danaher shares will prevail with possible volatility of 0.994%.
Pessimistic target level: 242.97
Optimistic target level: 245.41

Danaher Stock Forecast 07-26-2024.

Forecast target price for 07-26-2024: $243.14.
Negative dynamics for Danaher shares will prevail with possible volatility of 0.967%.
Pessimistic target level: 241.53
Optimistic target level: 243.89

Danaher Stock Forecast 07-27-2024.

Forecast target price for 07-27-2024: $243.75.
Positive dynamics for Danaher shares will prevail with possible volatility of 0.944%.
Pessimistic target level: 242.99
Optimistic target level: 245.31

DHR (DHR) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Aug. 258.50 246.56 264.65 6.84
Sep. 266.82 254.50 272.24 6.52
Oct. 266.26 256.38 277.82 7.72
Nov. 251.17 239.56 259.08 7.53
Dec. 239.74 233.19 248.46 6.15

Danaher forecast for this year


Danaher Stock Prediction for Aug 2024

An uptrend is forecast for this month with an optimal target price of $258.498. Pessimistic: $246.56. Optimistic: $264.65


Danaher Stock Prediction for Sep 2024

An uptrend is forecast for this month with an optimal target price of $266.822. Pessimistic: $254.50. Optimistic: $272.24


Danaher Stock Prediction for Oct 2024

An downtrend is forecast for this month with an optimal target price of $266.262. Pessimistic: $256.38. Optimistic: $277.82


Danaher Stock Prediction for Nov 2024

An downtrend is forecast for this month with an optimal target price of $251.165. Pessimistic: $239.56. Optimistic: $259.08


Danaher Stock Prediction for Dec 2024

An downtrend is forecast for this month with an optimal target price of $239.737. Pessimistic: $233.19. Optimistic: $248.46



Danaher (DHR) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 256.02 244.55 268.02 8.76
Feb 266.77 260.98 276.10 5.48
Mar 265.46 260.63 275.68 5.46
Apr 266.02 260.25 271.42 4.12
May 262.11 258.07 267.98 3.70
Jun 269.26 263.04 273.98 3.99
Jul 267.94 260.25 273.76 4.93
Aug 263.44 250.72 268.24 6.53
Sep 265.66 259.15 269.75 3.93
Oct 269.37 259.38 276.92 6.33
Nov 276.16 264.37 283.12 6.62
Dec 268.43 263.17 272.94 3.58

Danaher (DHR) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 273.32 267.19 282.50 5.42
Feb 275.42 264.62 289.49 8.59
Mar 256.14 249.51 260.26 4.13
Apr 240.18 229.42 249.43 8.02
May 235.64 224.59 241.75 7.10
Jun 224.10 214.37 232.10 7.64
Jul 231.47 220.61 241.19 8.53
Aug 224.34 216.33 229.99 5.94
Sep 234.39 225.53 240.79 6.34
Oct 238.99 226.44 244.84 7.52
Nov 246.01 235.68 249.46 5.52
Dec 245.84 233.28 255.30 8.63

Danaher (DHR) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 251.00 237.65 259.08 8.27
Feb 240.46 231.37 251.06 7.84
Mar 249.04 236.67 260.90 9.29
Apr 261.77 248.94 273.50 8.98
May 273.31 264.51 286.71 7.74
Jun 282.11 270.66 289.03 6.35
Jul 286.66 282.24 297.89 5.25
Aug 290.47 274.61 299.62 8.35
Sep 285.59 276.99 297.98 7.04
Oct 284.79 275.42 297.15 7.31
Nov 292.56 281.51 303.62 7.28
Dec 294.61 278.32 301.21 7.60

Danaher (DHR) Monthly Stock Prediction for 2028

Month Target Pes. Opt. Vol., %
Jan 284.51 276.14 298.25 7.41
Feb 291.88 275.74 296.58 7.03
Mar 293.31 280.58 303.78 7.64
Apr 298.03 289.27 303.04 4.54
May 293.02 283.18 301.64 6.12
Jun 307.58 303.28 311.89 2.76
Jul 306.29 299.86 312.73 4.11
Aug 318.09 300.94 323.65 7.02
Sep 321.20 306.81 335.82 8.64
Oct 329.75 314.51 346.37 9.20
Nov 338.98 329.01 347.52 5.33
Dec 333.05 320.69 338.88 5.37

Danaher information and performance

Danaher Address

2200 PENNSYLVANIA AVE. N.W., SUITE 800W, WASHINGTON, DC, US

Market Capitalization: 181 312 766 000 $

Market capitalization of the Danaher Corp. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of DHR shares in the company outstanding by the market price of one share.

EBITDA: 7 417 000 000 $

EBITDA of Danaher is earnings before interest, income tax and depreciation of assets.

PE Ratio: 44.83

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 3.127

Price/earnings to growth

DPS: 1.05

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0044

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 5.46

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: -0.251
Quarterly Revenue Growth YOY: -0.026
Trailing PE: 44.83

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 31.45

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 8.01

Enterprise Value (EV) /Revenue

EV To EBITDA: 25.53

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 740687000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Danaher (DHR) stock dividend

Danaher last paid dividends on 06/28/2024. The next scheduled payment will be on 07/26/2024. The amount of dividends is $1.05 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.